AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To hold Mirion Technologies, you need to believe in sustained demand for radiation detection across nuclear, medical and research markets, supported by modernization and compliance needs. The recent uptick in analyst earnings expectations ahead of the June 2026 quarter does not materially change the core near term catalyst around nuclear project execution, nor the central risk from potential long term pressure on nuclear build pipelines and policy.
The recent additions of Mirion to multiple Russell indexes in June 2026 look most relevant here, as they can influence trading activity and how quickly sentiment shifts around earnings revisions. Index inclusion sits alongside prior moves like the Vital software rollout and the Certrec acquisition, which together frame the key catalyst of growing higher margin, software enabled revenue tied to long dated nuclear and compliance projects.
Yet, despite this more optimistic analyst earnings tone, investors should be aware of the longer term risk that...
Read the full narrative on Mirion Technologies (it's free!)
Mirion Technologies' narrative projects $1.4 billion revenue and $145.5 million earnings by 2029. This requires 11.9% yearly revenue growth and about a $120 million earnings increase from $25.1 million today.
Uncover how Mirion Technologies' forecasts yield a $27.90 fair value, a 71% upside to its current price.
Four members of the Simply Wall St Community estimate Mirion’s fair value between US$15.14 and US$27.90, highlighting very different individual views. You can weigh those against the current focus on nuclear modernization and life extensions, which is central to Mirion’s opportunity but also linked to policy and project cycle risks that could influence future performance.
Explore 4 other fair value estimates on Mirion Technologies - why the stock might be worth as much as 71% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com